Trademark: 88221539
Word
MONONUCLEAR THERAPEUTICS
Status Date
Tuesday, September 8, 2020
Registration Number
6148263
Registration Date
Tuesday, September 8, 2020
Filing Date
Friday, December 7, 2018
Published for Opposition
Tuesday, October 22, 2019
39 Storage and retrieval of blood, tissue and stem cells for medical research, treatment and diagnostics; storage and retrieval of blood and blood components for medical research; biomedical services namely, the storage of human cells, specifically umbilical cord blood, umbilical cord blood cells, and stem cells for medical use and research use
44 Collection and testing of cord blood, blood, blood components, tissue and stem cells for medical research; medical diagnostic testing relating to cord blood, placenta tissue, human body
42 Research and development services in cellular therapy, in particularly, research and development in the field of treatment and medical diagnosis using cellular, molecular, biotechnological and genetic methods, and in the field of development of mononuclear cell therapy; research and development of individualized medicine, development of treatment plan and therapy adapted for individual patients; biomedical laboratory services for others, namely, the collection, extraction, processing, cryopreservation, analysis, screening, testing, typing and storage of umbilical cord blood, placenta, human tissues and stem cells; genetic testing services for research purposes; consultation, research and development relating to scientific research; research and development relating to medicine and healthcare products; development of testing methods in the fields of cellular therapy and mononuclear cell therapy
The mark consists of a design in the form of a small, shaded circle enclosed within two larger, concentric circles, the outer of which has an indent at the top which contains a small, shaded circle. The words "MONONUCLEAR THERAPEUTICS" are to the right of the design with "MONONUCLEAR" in bold above "THERAPEUTICS".
Color is not claimed as a feature of the mark.
"MONONUCLEAR THERAPEUTICS"
Dec 22, 2022
Teas Change Of Correspondence Received
Dec 22, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 22, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 8, 2020
Registered-Principal Register
Aug 1, 2020
Notice Of Acceptance Of Statement Of Use E-Mailed
Jul 31, 2020
Allowed Principal Register - Sou Accepted
Jul 8, 2020
Statement Of Use Processing Complete
Jun 17, 2020
Use Amendment Filed
Jul 8, 2020
Case Assigned To Intent To Use Paralegal
Jun 17, 2020
Teas Statement Of Use Received
Jan 29, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 29, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 17, 2019
Noa E-Mailed - Sou Required From Applicant
Oct 22, 2019
Official Gazette Publication Confirmation E-Mailed
Oct 22, 2019
Published For Opposition
Oct 2, 2019
Notification Of Notice Of Publication E-Mailed
Sep 25, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 25, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 18, 2019
Assigned To Lie
Sep 15, 2019
Approved For Pub - Principal Register
Sep 14, 2019
Examiner's Amendment Entered
Sep 14, 2019
Notification Of Examiners Amendment E-Mailed
Sep 14, 2019
Examiners Amendment E-Mailed
Sep 14, 2019
Examiners Amendment -Written
Sep 7, 2019
Teas/Email Correspondence Entered
Sep 6, 2019
Correspondence Received In Law Office
Sep 6, 2019
Teas Response To Office Action Received
Mar 13, 2019
Notification Of Non-Final Action E-Mailed
Mar 13, 2019
Non-Final Action E-Mailed
Mar 13, 2019
Non-Final Action Written
Mar 6, 2019
Assigned To Examiner
Jan 1, 2019
Notice Of Design Search Code E-Mailed
Dec 30, 2018
New Application Office Supplied Data Entered In Tram
Dec 11, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
